Sertraline and fluoxetine: Safe treatments for children and adolescents with epilepsy and depression

Epilepsy and Behavior

Volumn 10, Issue 3, 2007, Pages 417-425

  Thome Souza M S ^a   Kuczynski, E ^a   Valente, K D ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Children; Depression; Epilepsy; Selective serotonin reuptake inhibitors

Indexed keywords

CARBAMAZEPINE; CLOBAZAM; ETHOSUXIMIDE; FLUOXETINE; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TOPIRAMATE; VALPROIC ACID;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHILDHOOD DISEASE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EPILEPSY; FACE RASH; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MONOTHERAPY; REMISSION; SEIZURE; TONIC CLONIC SEIZURE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DEPRESSION; EPILEPSY; FEMALE; FLUOXETINE; HUMANS; MALE; NEUROLOGIC EXAMINATION; OUTCOME ASSESSMENT (HEALTH CARE); PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; SEROTONIN UPTAKE INHIBITORS; SERTRALINE;

EID: 34147152208     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2007.01.004     Document Type: Article

References (46)

1. Baker G.A., Jacoby A., and Chadwick D.W. The associations of psychopathology in epilepsy: a community study. Epilepsy Res 25 (1996) 29-39
2. Blumer D., and Altshuler L.L. Affective disorders. In: Engel J., and Pedley T.A. (Eds). Epilepsy: a comprehensive textbook (1997), Lippincott, Philadelphia 2083-2099
3. Edeh J., and Toone B. Relationship between interictal psychopathology and the type of epilepsy: results of a survey in general practice. Br J Psychiatry 151 (1987) 95-101
4. Emslie G.J., Rush A.J., Weinberg W.A., Gullion C.M., Rintelmann J., and Hugles C.W. Recurrence of major depressive disorder in hospitalized children and adolescents. J Am Acad Child Adolesc Psychiatry 36 (1997) 785-792
5. Indaco A., Carrieri B.P., Naapi C., Gentile S., and Striano S. Interictal depression in epilepsy. Epilepsy Res 12 (1992) 45-50
6. Jacoby A., Baker G.A., Steen N., Potts P., and Chadwick D.W. The clinical course of epilepsy and its psychosocial correlates: findings from a UK community study. Epilepsia 37 (1996) 148-161
7. Kovacs M., Feinberg T.L., Crouse-Novak M., Paulauskas S.L., Pollock M., and Finkelstein R. Depressive disorders in childhood: II. A longitudinal study of the risk for a subsequent major depression. Arch Gen Psychiatry 41 (1984) 643-649
8. Lambert M.V., and Robertson M.M. Depression in epilepsy: etiology, phenomenology, and treatment. Epilepsia 40 Suppl. 10 (1999) S21-S47
9. Mendez M.F., Cummings J.L., and Benson D.F. Depression in epilepsy: significance and phenomenology. Arch Neurol 43 (1986) 766-770
10. Nemeroff C.B. The neurobiology of depression. Sci Am 278 (1998) 42-49
11. Kanner A.M., Kozak A.M., and Frey M. The use of sertraline in patients with epilepsy: is it safe?. Epilepsy Behav 1 (2000) 100-105
12. Wiegartz P., Seidenberg M., Woodard A., et al. Co-morbid psychiatric disorder in chronic epilepsy: recognition and etiology of depression. Neurology 53 Suppl. 2 (1999) S3-S8
13. Lewinsohn P.M., Clarke G.N., Seeley J.R., and Rohde P. Major depression in community adolescents: age at onset, episode duration, and time to recurrence. J Am Acad Child Adolesc Psychiatry 33 (1994) 809-818
14. Thome-Souza S., Kuczynski E., Assumpção Jr. F., et al. Which factors may play a pivotal role in determining the type of psychiatric disorder in children and adolescents with epilepsy?. Epilepsy Behav 5 (2004) 988-994
15. Boylan L.S., Flint L.A., Labovitz D.L., Jackson S.C., Starner K., and Devinsky O. Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy. Neurology 27 62 (2004) 258-261
16. Gilliam F. Optimizing health outcomes in active epilepsy. Neurology 2002;23;58(8, Suppl. 5):S9-20.
17. Robertson M.M., and Trimble M.R. Depressive illness in patients with epilepsy: a review. Epilepsia 24 Suppl. 2 (1983) S109-S116
18. Brent D.A., Kalas R., Edelbrock C., Costello A.J., Dulcan M.K., and Conover N. Psychopathology and its relationship to suicidal ideation in childhood and adolescence. J Am Acad Child Psychiatry 25 (1986) 666-673
19. Brent D.A. Correlates of the medical lethality of suicide attempts in children and adolescents. J Am Acad Child Adolesc Psychiatry 26 (1987) 87-91
20. Brent D.A., and Kolko D.J. Suicidality in affectively disordered adolescent inpatients. J Am Acad Child Adolesc Psychiatry 29 (1990) 587-593
21. Kanner A.M., and Balabanov A. Depression and epilepsy: how close are they?. Neurology 58 Suppl. 5 (2002) S27-S39
22. Geller B., Zimerman B., Williams M., Bolhofner K., and Craney J.L. Bipolar disorder at prospective follow-up of adults who had prepubertal major depressive disorder. Am J Psychiatry 158 (2001) 125-127
23. Harrington R. The natural history and treatment of child and adolescent affective disorders. J Child Psychol Psychiatry 33 (1992) 1287-1302
24. Schmitz B. Antidepressant drugs: indications and guidelines for use in epilepsy. Epilepsia 43 Suppl. 2 (2002) 14-18
25. Lehmann A. Audiogenic seizure data in mice supporting new theories of biogenic amines mechanisms in the central nervous system. Life Sci 6 (1967) 1423-1431
26. Meldrum B.S., Anlezark G.M., Adam H.K., and Greenwod D.T. Anticonvulsant and proconvulsant properties of viloxazine hydrochloride: pharmacological and pharmacokinetic studies in rodents and epileptic baboon. Psychopharmacology (Berlin) 76 (1982) 212-217
27. Favale E., Rubino V., Mainardi P., Lunardi G., and Albano C. Anticonvulsant effect of fluoxetine in humans. Neurology 45 (1995) 1926-1927
28. Specchio L.M., Iudice A., Specchio N., et al. Citalopram as treatment of depression in patients with epilepsy. Clin Neuropharmacol 27 (2004) 133-136
29. Benazzi F. Symptoms of depression as possible markers of bipolar II disorder. Prog Neuropsychopharmacol Biol Psychiatry 30 (2006) 471-477
30. Ott D., Siddarth P., Gurbani S., et al. Behavioral disorders in pediatric epilepsy: unmet psychiatric need. Epilepsia 4 (2003) 591-597
31. Blumer D. Antidepressant and double antidepressant treatment for the affective disorder of epilepsy. J Clin Psychiatry 58 (1997) 3-11
32. Plioplys S. Depression in children and adolescents with epilepsy. Epilepsy Behav 4 (2003) S39-S45
33. Benazzi F. A continuity between bipolar II depression and major depressive disorder?. Prog Neuropsychopharmacol Biol Psychiatry 30 (2006) 1043-1050
34. Brent D.A. Antidepressants and pediatric depression: the risk of doing nothing. N Engl J Med. 351 (2004) 1598-1601
35. Geller B., Fox L.W., and Clark K.A. Rate and predictors of prepubertal bipolarity during follow-up of 6- to 12-year-old depressed children. J Am Acad Child Adolesc Psychiatry 33 (1994) 461-468
36. Strober M., Lampert C., Schmidt S., et al. The course of major depressive disorder in adolescents: 1. Recovery and risk of manic switching in a follow-up study of psychotic and nonpsychotic subtypes. J Am Acad Child Adolesc Psychiatry 32 (1993) 34-42
37. Dunner D.L. Clinical consequences of under-recognized bipolar spectrum disorder. Bipolar Disord 5 (2003) 456-463
38. Hirschfeld R.M.A., Calabrese J.R., Weissman M.M., et al. Screening for bipolar disorder in the community. J Clin Psychiatry 64 (2003) 53-59
39. Howard G.B., Shi L., Dial E., Oster E.F., Greenberg P.E., and Mallett D.A. Economic consequences of not recognizing bipolar disorder patients: a cross-sectional descriptive analysis. J Clin Psychiatry 64 (2003) 1201-1209
40. Valuck R.J., Libby A.M., Sills M.R., Giese A.A., and Allen R.R. Antidepressant treatment and risk of suicide attempt by adolescents with major depressive disorder. CNS Drugs 18 (2004) 1119-1132
41. Hall W.D. How have the SSRI antidepressants affected suicide risk?. Lancet 367 (2006) 1959-1962
42. March J., Silva S., Petrycki S., et al. Fluoxetine, cognitive-behavioural therapy, and their combination for adolescents with depression: Treatment for Adolescents with Depression Study (TADS) randomized controlled trial. JAMA 292 (2004) 807-820
43. Jureidini J.N., Doecke C.J., Mansfield P.R., Haby M.M., Menkes D.B., and Tonkin A.L. Efficacy and safety of antidepressants for children and adolescents. BMJ 328 (2004) 879-883
44. Mann J.J., Emslie G., Baldessarini R.J., et al. ACNP Task Force report on SSRIs and suicidal behavior in youth. Neuropsychopharmacology 31 (2006) 473-492
45. Hammad T.A., Laughren T., and Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry 63 (2006) 332-339
46. Newman T.B. A black-box warning for antidepressants in children?. N Engl J Med 351 (2004) 1595-1598